Technical Analysis for HELX - Franklin Genomic Advancements ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bullish Centerline Cross | Bullish | -0.07% | |
| Stochastic Reached Overbought | Strength | -0.07% | |
| Upper Bollinger Band Walk | Strength | -0.07% | |
| Multiple of Ten Bullish | Other | -0.07% | |
| BB Squeeze Ended | Range Expansion | -0.07% | |
| Outside Day | Range Expansion | -0.07% | |
| Above Upper BB | Strength | -0.07% | |
| Overbought Stochastic | Strength | -0.07% | |
| Up 3 Days in a Row | Strength | -0.07% | |
| Upper Bollinger Band Touch | Strength | -0.07% |
| Alert | Time |
|---|---|
| Fell Below Upper Bollinger Band | 36 minutes ago |
| Up 1% | about 20 hours ago |
| 60 Minute Opening Range Breakout | about 23 hours ago |
| Rose Above Previous Day's High | about 23 hours ago |
| Outside Day | about 23 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life.
Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine
Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment
Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovation
Keywords: Exchange Traded Fund ETF Biotechnology Life Sciences Biology Emerging Technologies Health & Biotech ETF Molecular Biology Genetics Portfolio Management Quality Of Life Personalized Medicine DNA DNA Sequencing
Classification
Keywords: Exchange Traded Fund ETF Biotechnology Life Sciences Biology Emerging Technologies Health & Biotech ETF Molecular Biology Genetics Portfolio Management Quality Of Life Personalized Medicine DNA DNA Sequencing
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Date | Title |
|---|---|
| Oct 22 | Why Is Medpace Stock Diving On Tuesday? |
| Indicator | Value |
|---|---|
| 52 Week High | 33.9761 |
| 52 Week Low | 28.3 |
| Average Volume | 6,960 |
| 200-Day Moving Average | 31.43 |
| 50-Day Moving Average | 29.97 |
| 20-Day Moving Average | 29.54 |
| 10-Day Moving Average | 29.73 |
| Average True Range | 0.46 |
| RSI (14) | 60.94 |
| ADX | 11.65 |
| +DI | 40.43 |
| -DI | 20.93 |
| Chandelier Exit (Long, 3 ATRs) | 29.37 |
| Chandelier Exit (Short, 3 ATRs) | 30.05 |
| Upper Bollinger Bands | 30.47 |
| Lower Bollinger Band | 28.62 |
| Percent B (%b) | 1.14 |
| BandWidth | 6.27 |
| MACD Line | 0.02 |
| MACD Signal Line | -0.14 |
| MACD Histogram | 0.1693 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 31.85 | ||||
| Resistance 3 (R3) | 31.73 | 31.23 | 31.66 | ||
| Resistance 2 (R2) | 31.23 | 30.95 | 31.29 | 31.59 | |
| Resistance 1 (R1) | 30.98 | 30.77 | 31.11 | 31.10 | 31.53 |
| Pivot Point | 30.48 | 30.48 | 30.55 | 30.54 | 30.48 |
| Support 1 (S1) | 30.23 | 30.20 | 30.36 | 30.35 | 29.91 |
| Support 2 (S2) | 29.73 | 30.02 | 29.79 | 29.85 | |
| Support 3 (S3) | 29.48 | 29.73 | 29.78 | ||
| Support 4 (S4) | 29.60 |
